Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

Conflicts of interest. IOM panel backs public disclosure of drug company payments.

Kaiser J.

Science. 2009 May 1;324(5927):579. doi: 10.1126/science.324_579a. No abstract available.

PMID:
19407172
2.

Conflicts of interest at the NIH--resolving the problem.

Steinbrook R.

N Engl J Med. 2004 Sep 2;351(10):955-7. No abstract available.

PMID:
15342801
3.

Toward a harmonized and centralized conflict of interest disclosure: progress from an IOM initiative.

Lichter AS, McKinney R.

JAMA. 2012 Nov 28;308(20):2093-4. doi: 10.1001/jama.2012.51172. No abstract available.

PMID:
23188024
4.

IOM warns about physician-pharma conflicts of interest.

Landers SJ, O'Reilly KB.

Del Med J. 2009 Jul;81(7):261-3. No abstract available.

PMID:
19902777
5.

Conflicts of interest at the NIH: no easy solution.

Resnik DB.

Hastings Cent Rep. 2005 Jan-Feb;35(1):18-20. No abstract available.

PMID:
15799496
6.

Ethics. Senate inquiry on research conflicts shifts to grantees.

Kaiser J.

Science. 2008 Jun 27;320(5884):1708. doi: 10.1126/science.320.5884.1708. No abstract available.

PMID:
18583586
7.

What's wrong with money in science.

Stossel T, Shaywitz D.

Washington Post. 2006 Jul 2:B3. No abstract available.

PMID:
16838447
8.

Trust, but verify.

[No authors listed]

Nature. 2009 Sep 17;461(7262):315. doi: 10.1038/461315a. No abstract available.

PMID:
19759574
9.

Stealth merger: drug companies and government medical research.

Willman D.

Los Angeles Times. 2003 Dec 7:A1, A32-3. No abstract available.

PMID:
14971391
10.

Conflicts of interest in medical education: recommendations from the Pew task force on medical conflicts of interest.

Korn D, Carlat D.

JAMA. 2013 Dec 11;310(22):2397-8. doi: 10.1001/jama.2013.280889. No abstract available.

PMID:
24327035
12.

Trust in the medical literature--and Viewpoints in JAMA Internal Medicine.

Steinbrook R, Redberg RF.

JAMA Intern Med. 2013 Jun 24;173(12):1047-8. doi: 10.1001/jamainternmed.2013.6281. No abstract available.

PMID:
23609117
13.

New rules on conflict of interest: what has to be done in Europe?

Jirillo A, Vascon F.

Tumori. 2010 Jan-Feb;96(1):180-1. No abstract available.

14.

Subverting U.S. health.

[No authors listed]

Los Angeles Times. 2003 Dec 7:M4. No abstract available.

PMID:
14971390
15.

Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.

Tereskerz PM.

Account Res. 2003 Jul-Sep;10(3):137-58. No abstract available.

PMID:
14979317
16.

Ethics. Private money, public disclosure.

Kaiser J.

Science. 2009 Jul 3;325(5936):28-30. doi: 10.1126/science.325_28. No abstract available.

PMID:
19574366
17.

A unique researcher identifier for the Physician Payments Sunshine Act.

Carpenter D, Joffe S.

JAMA. 2011 May 18;305(19):2007-8. doi: 10.1001/jama.2011.651. No abstract available.

18.
19.

Institutes in pharma cash probe.

Ledford H.

Nature. 2008 Jun 19;453(7198):963. doi: 10.1038/453963a. No abstract available.

PMID:
18563109
20.

Money in biomedicine: The senator's sleuth.

Wadman M.

Nature. 2009 Sep 17;461(7262):330-4. doi: 10.1038/461330a. No abstract available.

PMID:
19759593

Supplemental Content

Support Center